December 5, 2023
December 5, 2023
December 5, 2023
2023 marks a pivotal year for the autoimmune space as numerous releases of biosimilar adalimumab challenge the market dominance of AbbVie’s Humira, one of the best-selling brands in the United…
December 1, 2023
Antibody-drug conjugates have proven to be a versatile and effective tool in treating a wide range of tumor types, establishing the drug class as a valuable weapon against cancer. The approval of…
November 30, 2023
November 29, 2023
November 29, 2023
November 29, 2023
Scleroderma, also known as systemic sclerosis (SSc), is a rare, progressive, and debilitating autoimmune disorder characterized by skin fibrosis, systemic inflammation, and vasculopathy that…
November 28, 2023
November 22, 2023
November 22, 2023
November 22, 2023
November 21, 2023